Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-02-23 @ 8:06 PM
Study NCT ID:
NCT02316002
Status:
COMPLETED
Last Update Posted:
2025-11-06
First Post:
2014-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-10
First Submit QC Date:
None
Study First Post Date:
2014-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-14
Results First Submit QC Date:
None
Results First Post Date:
2019-11-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-04
Last Update Post Date:
2025-11-06
Last Update Post Date Type:
ESTIMATED